⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28304721 | 0.98 | — | — | |
| SCHEMBL28235743 | 0.95 | ALDH1A1 (0.48) | — | |
| SCHEMBL270347 | 0.84 | — | — | |
| SCHEMBL921218 | 0.81 | ALDH1A1 (0.48) | — | |
| SCHEMBL10745935 | 0.79 | — | — | |
| SCHEMBL14416288 | 0.79 | — | — | |
| SCHEMBL256707 | 0.79 | — | — | |
| SCHEMBL499995 | 0.79 | ALDH1A1 (0.50) | — | |
| SCHEMBL10431713 | 0.78 | — | — | |
| SCHEMBL183492 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110082441-A | The method and kit of detection disabling essence | 中国检验检疫科学研究院 | 2019-08-02 | — | — | CN | claimed |
| CN-109985626-A | For the method for furfural liquid-phase hydrogenatin ethyl furfuryl group ether and the preparation method of catalyst and catalyst | 天津大学 | 2019-07-09 | — | — | CN | claimed |
| EP-2045251-B1 | COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES | CONSEJO SUPERIOR INVESTIGACION (ES) | 2015-11-18 | — | — | EP | claimed |
| US-8785430-B2 | Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-07-22 | — | — | US | claimed |
| US-20130237529-A1 | COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS | 2013-09-12 | — | — | US | claimed |
| US-8252786-B2 | Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2012-08-28 | — | — | US | claimed |
| US-20110160189-A1 | COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2011-06-30 | — | — | US | claimed |
| EP-2045251-A1 | COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES | Consejo Superior de Investigaciones Cientificas (ES) | 2009-04-08 | — | — | EP | claimed |
| EP-0718281-B1 | CYCLOHEXANEDIUREA DERIVATIVE AND PROCESS FOR PRODUCING THE SAME | NISSIN FOOD PRODUCTS LTD (JP) | 2001-06-27 | — | — | EP | claimed |
| CN-108948019-B | Focal adhesion kinase inhibitors and uses thereof | 广东东阳光药业有限公司 | 2022-07-08 | — | — | CN | disclosed |
| EP-3750892-A1 | NOVEL 5-CYCLOPROPYL-FURO[3,4-C]PYRIDINE-3,4(1H,5H)-DIONE 1,1' SUBSTITUTED DERIVATIVES AND THEIR USES | Yerevan State University (AM) | 2020-12-16 | — | — | EP | disclosed |
| CN-110082441-A | The method and kit of detection disabling essence | 中国检验检疫科学研究院 | 2019-08-02 | — | — | CN | disclosed |
| CN-110003150-A | A method of utilizing Furfural Production from Xylose | 南开大学 | 2019-07-12 | — | — | CN | disclosed |
| CN-109985626-A | For the method for furfural liquid-phase hydrogenatin ethyl furfuryl group ether and the preparation method of catalyst and catalyst | 天津大学 | 2019-07-09 | — | — | CN | disclosed |
| US-4472300-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-09-18 | — | — | US | disclosed |
| US-4472309-A | ANTIMICROBIAL | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-09-18 | — | — | US | disclosed |
| US-4304718-A | ANTIBIOTICS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-12-08 | — | — | US | disclosed |
| US-4264498-A | REACTED WITH AN ACID, ITS ACID HALIDE, OR ANHYDRIDE IN THE PRESENCE OF BORON TRIHALIDE AND AN ORGANIC BASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1981-04-28 | — | — | US | disclosed |
| US-4207234-A | 4-Unsubstituted azetidinone derivatives and process for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-06-10 | — | — | US | disclosed |
| US-4181800-A | ANTIBIOTICS FROM SUBSTITUTED PERHYDRO-S-TRIAZINES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1980-01-01 | — | — | US | disclosed |